$490,000 of BIOMARIN PHARMACEUTICAL INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"HR 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS OF THE BILL HR 2630: SAFE STEP ACT; ALL PROVISIONS OF THE BILL HR 2666: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); PROVISIONS RELATED TO OUTCOME BASED ARRANGEMENTS (OBA) AND VALUE BASED ARRANGEMENTS (VBA) HR 4758: ACCELERATING KIDS' ACCESS TO CARE ACT: ALL PROVISIONS OF THE BILL HR 7384: CREATING HOPE REAUTHORIZATION ACT OF 2024; ALL PROVISIONS OF THE BILL HR 8574: 340B AFFORDABLE CARE FOR COMMUNITIES AND ENSURING A STRONG SAFETY-NET (ACCESS) ACT; ALL PROVISIONS OF THE BILL HR 9184: PATIENT ACCESS ACT OF 2024; ALL PROVISIONS OF THE BILL S 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS OF THE BILL S 4583: CREATING HOPE REAUTHORIZATION ACT OF 2024; ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING GENETIC SCREENING, LONG TERM FOLLOW UP, CURES 3.0, AND ORPHAN DRUG ACT HR 2666: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); ALL PROVISIONS OF THE BILL HR 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS OF THE BILL HR 6094: PROVIDING REALISTIC OPPORTUNITY TO EQUAL AND COMPARABLE TREATMENT FOR RARE ACT (PROTECT RARE ACT); ALL PROVISIONS OF THE BILL S 4204: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); ALL PROVISIONS OF THE BILL S 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING MEDICAID ACCESS TO RARE DISEASE THERAPIES AND ACCESS TO OUT OF STATE PROVIDER TELEHEALTH"
You can find more data on corporate lobbying on Quiver Quantitative.
BMRN Insider Trading Activity
BMRN insiders have traded $BMRN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BMRN stock by insiders over the last 6 months:
- CHARLES GREG GUYER (EVP, Chief Technical Officer) sold 5,278 shares for an estimated $350,323
- ERIN BURKHART (GVP, Chief Accounting Officer) sold 714 shares for an estimated $64,260
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BMRN Hedge Fund Activity
We have seen 271 institutional investors add shares of BMRN stock to their portfolio, and 284 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VIKING GLOBAL INVESTORS LP added 2,689,729 shares (+38.1%) to their portfolio in Q3 2024, for an estimated $189,061,051
- AVORO CAPITAL ADVISORS LLC removed 2,519,401 shares (-55.3%) from their portfolio in Q3 2024, for an estimated $177,088,696
- 1832 ASSET MANAGEMENT L.P. added 1,141,200 shares (+4920.9%) to their portfolio in Q3 2024, for an estimated $80,214,948
- CAMBER CAPITAL MANAGEMENT LP removed 1,100,000 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $77,319,000
- BARCLAYS PLC removed 830,789 shares (-74.3%) from their portfolio in Q3 2024, for an estimated $58,396,158
- STATE STREET CORP removed 812,906 shares (-8.4%) from their portfolio in Q3 2024, for an estimated $57,139,162
- CAPITAL RESEARCH GLOBAL INVESTORS added 802,389 shares (+8.3%) to their portfolio in Q3 2024, for an estimated $56,399,922
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
